Liminatus Pharma Inc. Class A Common Stock (LIMN)
FairStock Score: 17/100 — RISKY
| Current Price | $0.2 |
| Market Cap | $90,74,257 |
| P/E Ratio | — |
| ROE | —% |
| Dividend Yield | —% |
| Sector | Healthcare |
Data from SEC filings. Not investment advice. Scoring methodology
FairStock Score: 17/100 — RISKY
| Current Price | $0.2 |
| Market Cap | $90,74,257 |
| P/E Ratio | — |
| ROE | —% |
| Dividend Yield | —% |
| Sector | Healthcare |
Data from SEC filings. Not investment advice. Scoring methodology